Published: 2022-03-04

ISSUE HIGHLIGHTS

Editorials

Using Genomics to Improve Pigmented Lesion Management & Health Outcomes

Clay Cockerell, Roger Ceilley, Mark Lebwohl, Darrell Rigel
| DOI https://doi.org/10.25251/skin.6.2.1

Page 87-89

PDF

In-Depth Reviews

Granulomatous Mastitis with Erythema Nodosum: A Case Report and Systematic Review

Nwanneoma Ngonadi, Brian Florenzo, Richard Flowers, Seth Martin
| DOI https://doi.org/10.25251/skin.6.2.2

Page 90-99

PDF

Original Research

Exploring the Psychosocial Impact on Parents of Adolescents Diagnosed With Hidradenitis Suppurativa: A Retrospective Claims-Based Analysis

Jay Yang, Joslyn Kirby, Steven Maczuga
| DOI https://doi.org/10.25251/skin.6.2.3

Page 100-108

PDF

Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma

Daniel Siegel , Christopher Murphy , Kent Wangsness, Allyson Perry , Ian Smith
| DOI https://doi.org/10.25251/skin.6.2.4

Page 109-121

PDF

Research Letters

Trends in Medicare Reimbursement within Dermatology: 2011-2021

Kyle Lauck, Quoc-Bao Nguyen, Adelaide Hebert
| DOI https://doi.org/10.25251/skin.6.2.5

Page 122-131

PDF

Weekly Isotretinoin Therapy (WIT) Study: A Potential Alternative for the Treatment of Moderate Acne Vulgaris

Samantha Karlin, Alexandra Ritter, Courtney Linkous, Katherine Wehlage, Lara Wine Lee
| DOI https://doi.org/10.25251/skin.6.2.6

Page 132-134

PDF KOL SUMMARY

Brief Articles

Successful Dupilumab Treatment of Atopic Dermatitis in a Liver Transplant Patient

Amanda Krenitsky, Sairekha Ravichandran, Joel Cohen, Jonathan Braue, Lilia Correa-Selm
| DOI https://doi.org/10.25251/skin.6.2.7

Page 135-137

PDF

Wells Syndrome with Sustained Response to Omalizumab

Kezia Surjanto, Gage Rensch, Garrett Vick, Andrea Murina
| DOI https://doi.org/10.25251/skin.6.2.8

Page 138-142

PDF

Case Report and Review of Eccrine Porocarcinoma in Skin of Color

Sadhana Sruveera Sathi, Elizabeth M. Dugan, Maral Skelsey
| DOI https://doi.org/10.25251/skin.6.2.9

Page 143-148

PDF

Ustekinumab in the Treatment of Erythema Nodosum with Underlying Crohn’s Disease: A Case Report

Antonio Sanín-Guana, Mark G. Lebwohl
| DOI https://doi.org/10.25251/skin.6.2.10

Page 149-151

PDF

A Case of Amelanotic Melanoma in the Setting of Cemiplimab Therapy for Invasive Squamous Cell Carcinoma

Victoria Lee, Mark Hoffman, Arlene Ruiz de Luzuriaga
| DOI https://doi.org/10.25251/skin.6.2.11

Page 152-156

PDF

SARS-Cov-2 Infection Uncovering Latent Mycobacterium Leprae Infection

Christopher Mancuso, DO, MHS, Paloma Reiter, DO, Regina Zambrano, DO, Ritu Saini, MD, Suzanne Sirota-Rozenberg, DO
| DOI https://doi.org/10.25251/skin.6.2.12

Page 157-161

PDF

A Diagnostic Challenge: Desmoplastic Melanoma

Katie O'Connell, Ryan Svoboda, Bryan Anderson, Klaus Helm, Kimberly Ken
| DOI https://doi.org/10.25251/skin.6.2.13

Page 162-165

PDF

COVID Concepts

Herpes Zoster Post-COVID-19 Vaccination in Young Adults (Under 35)

Sophie Guenin, Emily Elbogen , Mindy Kresch , Mark Lebwohl
| DOI https://doi.org/10.25251/skin.6.2.14

Page 166-169

PDF

Poster Presenations From Winter Clinical 2022 and FC PANP 2021: Psoriasis

Low Risk of Serious Infections and Infections of Interest in Psoriasis Patients Treated with Guselkumab (GUS) for up to 5 Years in VOYAGE (VOY) 1&2 Phase 3 Trials

Richard Langley, Diamant Thaci, Andrew Blauvelt, Tsen-Fang Tsai, Megan Miller, Jenny Yu, Yaung-Kaung Shen, Yin You, Ya-Wen Yang, Kim Papp, Luis Puig, Peter Foley
| DOI https://doi.org/10.25251/skin.6.supp.1

Page s1

Poster PDF

Guselkumab (GUS) in Psoriasis Patients With a History of Malignancy: 5-Year Safety From VOYAGE (VOY)1&2

Andrew Blauvelt, Diamant Thaci, Kim Papp, Vincent Ho, Kamran Ghoreschi, Byung Soo Kim, Megan Miller, Yaung-Kaung Shen, Yin You, Jenny Yu, Ya-Wen Yang, Jeffrey Crowley, Peter Foley
| DOI https://doi.org/10.25251/skin.6.supp.2

Page s2

Poster PDF

Mean Percentage Improvement in Psoriasis Area and Severity Index (PASI) Response and Absolute PASI Through 5 Years of Continuous Treatment With Guselkumab (GUS) in VOYAGE 1

Joe Merola, Luis Puig, Megan Miller, Yin You, Yaung-Kaung Shen, Ya-Wen Yang, Andrew Blauvelt
| DOI https://doi.org/10.25251/skin.6.supp.3

Page s3

Poster PDF

Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor, in Moderate to Severe Plaque Psoriasis: 52-Week Efficacy Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials

Richard Warren , April Armstrong , Melinda Gooderham, Bruce Strober , Diamant Thaci, Shinichi Imafuku, Howard Sofen, Lynda Spelman, Neil Korman, Min Zheng, Elizabeth Colston, John Throup , Sundeep Kundu, Renata Kisa, Subhashis Banerjee, Andrew Blauvelt
| DOI https://doi.org/10.25251/skin.6.supp.4

Page s4

Poster PDF

Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Long-Term Extension Trial of a Novel Therapeutic Aryl Hydrocarbon Receptor Modulating Agent

Bruce Strober , Linda Stein Gold, Robert Bissonnette, April Armstrong , Andrew Blauvelt, Leon Kircik, Philip Brown, Anna Tallman, Mark Lebwohl
| DOI https://doi.org/10.25251/skin.6.supp.5

Page s5

Poster PDF

Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Secondary Efficacy Outcomes from Two Pivotal Phase 3 Trials

Linda Stein Gold, Andrew Blauvelt, April Armstrong , Seemal Desai, Howard Sofen, Lawrence Green, Steve Tyring, Laura Ferris, Philip Brown, David Rubenstein, Stephen Piscitelli, Anna Tallman, Leon Kircik
| DOI https://doi.org/10.25251/skin.6.supp.6

Page s6

Poster PDF

Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Efficacy by Baseline Disease Characteristics and Demographics in Two Pivotal Phase 3 Trials

Leon Kircik, Linda Stein Gold, James Del Rosso, Seemal Desai, Brad Glick, Howard Sofen, Anna Tallman, David Rubenstein, Janine Fournier, Philip Brown
| DOI https://doi.org/10.25251/skin.6.supp.7

Page s7

Poster PDF

Patient Satisfaction with Tapinarof Cream 1% Once Daily for Plaque Psoriasis in a Long-Term Extension Trial

Jerry Bagel, Linda Stein Gold, James Del Rosso, Neal Bhatia, Sandy Johnson , Paul Yamauchi, Angela Moore, Anna Tallman
| DOI https://doi.org/10.25251/skin.6.supp.8

Page s8

Poster PDF

Calcipotriene And Betamethasone Dipropionate Cream Demonstrates High Treatment Success In Patients With Scalp Psoriasis

Andreas Pinter, Morten Præstegaard, Johan Selmer, Adam Reich
| DOI https://doi.org/10.25251/skin.6.supp.9

Page s9

Poster PDF

Calcipotriene and betamethasone dipropionate cream demonstrates superior efficacy in moderate plaque psoriasis compared to topical suspension: a subgroup analysis of a phase 3 trial

Linda Stein Gold, John Selmer, Morten Præstegaard, April Armstrong
| DOI https://doi.org/10.25251/skin.6.supp.10

Page s10

Poster PDF

Immunogenicity of Guselkumab (GUS) Among Psoriasis Patients in VOYAGE (VOY) 1&2 Studies

Kristian Reich , April Armstrong , Yaowei Zhu, Megan Miller, Yin You, Yaung-Kaung Shen, Ya-Wen Yang, Peter Foley, Christopher Griffiths, Bruce Strober
| DOI https://doi.org/10.25251/skin.6.supp.11

Page s11

Poster PDF

Short Communications

Desmoplastic Malignant Melanoma Clinically Presenting as a “Cyst”

Haley Danielle Heibel, Robin Burger, Clay Cockerell
| DOI https://doi.org/10.25251/skin.6.2.15

Page 170-171

PDF

Percutaneous Penetration: Reliability of Mathematical Models

Anuk Burli, Rebecca Law, Howard Maibach
| DOI https://doi.org/10.25251/skin.6.2.16

Page 172-173

PDF

Subacute Cutaneous Lupus Erythematosus Associated with Ramucirumab Therapy

Elise Hogan, Kelsey Nusbaum, Anne Householder
| DOI https://doi.org/10.25251/skin.6.2.17

Page 174-176

PDF

Surprise Medical Billing Reform: Considerations for Dermatology

Yuangao Liu, Natalie Skopicki, Harrison Nguyen, Travis Blalock
| DOI https://doi.org/10.25251/skin.6.2.18

Page 177-179

PDF

Acne & Rosacea

Treating Acne in Obese and Morbidly Obese Patients With Tazarotene 0.045% Lotion: Post Hoc Analysis of Pooled Phase 3 Data

Jonette Keri, Leon Kircik, Lawrence Green, Glynis Ablon, William Werschler, Emil Tanghetti, Zoe Draelos, Eric Guenin
| DOI https://doi.org/10.25251/skin.6.supp.12

Page s12

Poster PDF

Marked Truncal Acne Response to Sarecycline Monotherapy in Different Ethnicities

Angela Moore, Stephen Moore, Luke Moore, Ayman Grada, Stephen Tyring
| DOI https://doi.org/10.25251/skin.6.supp.13

Page s13

Poster PDF

Encapsulated benzoyl peroxide (E-BPO): A novel formulation of BPO for long-term management of rosacea

Neal Bhatia, Edward Lain, Hilary Baldwin, Sam Brantman, James Del Rosso, Raja Sivamani
| DOI https://doi.org/10.25251/skin.6.supp.14

Page s14

Poster PDF

Critical Evaluation of Benzoyl Peroxide in Rosacea: Old Challenges and New Clinical Opportunities With Encapsulated Benzoyl Peroxide 

James Del Rosso, Neal Bhatia, Hilary Baldwin, Linda Stein Gold, Seemal Desai, Sam Brantman
| DOI https://doi.org/10.25251/skin.6.supp.15

Page s15

Poster PDF

A New Frontier in Acne Treatment: Encapsulated Benzoyl Peroxide and Tretinoin  

James Del Rosso, Jeffrey Sugarman , Michael Gold, Krysten Arekapdui, Lawrence Green
| DOI https://doi.org/10.25251/skin.6.supp.16

Page s16

Poster PDF

Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Phase 2 Study of the First Triple-Combination Drug

James Del Rosso, Leon Kircik, Linda Stein Gold, Hilary Baldwin, Jonathan Weiss, David Pariser, Valerie Callender, Edward Lain, Michael Gold, Kenneth Beer, Zoe Draelos, Neil Sadick, ; Radhakrishnan Pillai, Varsha Bhatt, Emil Tanghetti
| DOI https://doi.org/10.25251/skin.6.supp.17

Page s17

Poster PDF

Tazarotene 0.045% Lotion for Females With Acne: Analysis of Two Different Adult Age Groups

Neil Sadick, Fran Cook-Bolden, Kenneth Beer, Zoe Draelos, Leon Kircik, Emil Tanghetti, Eric Guenin
| DOI https://doi.org/10.25251/skin.6.supp.18

Page s18

Poster PDF

Skin Cancer

Patient-Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis in Real-world Settings: PROAK Study Protocol

Brian Berman, April Armstrong , Mark Lebwohl, Ayman Grada, Neal Bhatia, Vishal Patel, Darrell Rigel, James Del Rosso, Todd Schlesinger, Leon Kircik, Raidah Salem, Ismail Kasujee
| DOI https://doi.org/10.25251/skin.6.supp.19

Page s19

Poster PDF

Tirbanibulin Ointment Eradicates HPV-57 (+) Periungual Squamous Cell Carcinoma

Angela Moore, Stephen Moore, Qin He, Peter Rady, Ayman Grada, Stephen Tyring
| DOI https://doi.org/10.25251/skin.6.supp.20

Page s20

Poster PDF

Appropriate utilization of the prognostic 40-gene expression profile (40-GEP) test for cutaneous squamous cell carcinoma (cSCC) demonstrated by clinical reports and physician evaluation of real-world cases

Aaron Farberg, Jennifer Siegel, Briana Rackely , Alison Fitzgerald, Sarah Kurley, Robert Cook
| DOI https://doi.org/10.25251/skin.6.supp.21

Page s21

Poster PDF

Evidence review of the prognostic 40-gene expression profile test for cutaneous squamous cell carcinoma

Matthew Goldberg, Sarah Kurley, Jennifer Siegel, Alison Fitzgerald, Robert Cook
| DOI https://doi.org/10.25251/skin.6.supp.22

Page s22

Poster PDF

Attitudes of Patients with Cutaneous Melanoma Towards Prognostic Testing Using Gene Expression Profiling

Lorrie-Beth Miley, Kelli Ahmed, Jennifer Siegel, Sonia Morgan-Linnell
| DOI https://doi.org/10.25251/skin.6.supp.23

Page s23

Poster PDF

31-Gene Expression Profile Testing Survival Benefit in a Population-based Analysis of Cutaneous Melanoma Patients ≥65 Years of Age

Christine Bailey, Brian Martin, Valentina Petkov, Jennifer Siegel, Sarah Kurley, Kyle Covington
| DOI https://doi.org/10.25251/skin.6.supp.24

Page s24

Poster PDF

Complete clearance of actinic keratosis with tirbanibulin ointment 1% is not correlated with the severity of local skin reactions

Brian Berman, Todd Schlesinger, Neal Bhatia, Ayman Grada, Laura Padulles, Francisco Hernandez, david Cutler, Mark Lebwohl
| DOI https://doi.org/10.25251/skin.6.supp.25

Page s25

Poster PDF

Impact of prior treatment in the efficacy and tolerability of tirbanibulin ointment 1% for actinic keratosis: pooled results from two Phase 3 studies

Todd Schlesinger, Neal Bhatia, Brian Berman, Ayman Grada, Laura Padulles, Francisco Hernandez, David Cutler, Mark Lebwohl
| DOI https://doi.org/10.25251/skin.6.supp.26

Page s26

Poster PDF

Efficacy of tirbanibulin ointment 1% across different patient populations: pooled results from two Phase 3 studies

Brian Berman, Adria Gual, Ayman Grada, Emilio Fumero, Laura Padulles, Francisco Hernandez
| DOI https://doi.org/10.25251/skin.6.supp.s27

Page s27

Poster PDF

SKINmages: Clinical Images in Dermatology

Auricular Distortion Following Cryotherapy

Jason Bard, Heather Kornmehl , Joesph Wentzell
| DOI https://doi.org/10.25251/skin.6.2.19

Page 180-182

PDF

An Uncommon Presentation Of Erosive Pustular Dermatosis: A Large, Crusted Plaque On The Scalp

James MacKenzie, Miriam Sagher, Ethan Sagher, Ben Friedman, Jesse Veenstra
| DOI https://doi.org/10.25251/skin.6.2.20

Page 183-185

PDF

Atopic Dermatitis

Long-Term Safety and Disease Control of Ruxolitinib Cream Among Adolescents With Atopic Dermatitis: Results From Two Phase 3 Studies

Lawrence Eichenfeld, Eric Simpson, Kim Papp, Jacek Szepietowski, Leon Kircik, Darryl Toth, Seth Forman, Michael Kuligowski, May Venturanza, Haobo Ren, Amy Paller
| DOI https://doi.org/10.25251/skin.6.supp.28

Page s28

Poster PDF

Efficacy and safety of tralokinumab in adolescents with moderate-to- severe atopic dermatitis: results of the phase 3 ECZTRA 6 trial

Amy Paller, Andrew Blauvelt, Weily Soong, Shinichi Imafuku, Chih-ho Hong, Marie Schuttelaar, Petra Amoudruz, Azra Kurbasic, Lise Soldbro, Katja Lophaven, Michael Cork, Anthony Bewley, Eric Simpson
| DOI https://doi.org/10.25251/skin.6.supp.s29

Page s29

Poster PDF

Miscellaneous

A Rare Case of Empedobacter Brevis Cutaneous Infection Treated Successfully with Oral Sarecycline  

Susuana Adjei, Austinn Miller, Laurie Temiz, Stephen Tyring
| DOI https://doi.org/10.25251/skin.6.supp.s30

Page s30

Poster PDF

Therapeutic Recommendations for the Treatment of Toenail Onychomycosis in the US

Shari Lipner, Warren Joseph , Tracey Vlahovic, Richard Scher, Phoebe Rich, Mahmoud Ghannoum, Ralph Daniel, Boni Elewski
| DOI https://doi.org/10.25251/skin.6.supp.s31

Page s31

Poster PDF